COMMUNIQUÉS West-GlobeNewswire

Innovation Pharmaceuticals Requesting European Medicines Agency (EMA) Input for International Phase 3 Brilacidin Oral Mucositis Program
15/03/2019
BEVERLY, Mass., March 15, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to inform shareholders that necessary documentation has [...]
Matrix Medical Network showcases state-of-the-art mobile health clinic at RISE Nashville
15/03/2019
Summit highlights company’s national fleet providing an inside look at the future of population health SCOTTSDALE, Ariz., March 15, 2019 (GLOBE NEWSWIRE) -- Matrix Medical Network (Matrix) builds upon last year’s mobile [...]
Selecta Biosciences Announces Fourth Quarter and Year End 2018 Financial Results and Provides Corporate Update
15/03/2019
Phase 2 head-to-head (COMPARE) clinical trial of SEL-212 vs. KRYSTEXXA® to begin in 1Q19, interim six-month data expected in 4Q19 Collaboration with CureCN projected to dose first patient with combination of ImmTOR + [...]
Extendicare Announces March 2019 Dividend of C$0.04 per Share
15/03/2019
MARKHAM, Ontario, March 15, 2019 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common [...]
Gemphire Therapeutics Reports Fourth Quarter and Fiscal Year 2018 Financial Results
15/03/2019
LIVONIA, Mich., March 15, 2019 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for the treatment of [...]
AzurRx BioPharma to Present at the 2019 Annual Roth Capital Conference (March 19) and the Oppenheimer 29th Annual Healthcare Conference (March 20)
15/03/2019
BROOKLYN, N.Y., March 15, 2019 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc.(NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]
Checkpoint Therapeutics Reports Full-Year 2018 Financial Results and Recent Corporate Highlights
15/03/2019
NEW YORK, March 15, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]
ProMIS Neurosciences Announces Fiscal Year 2018 Annual Results
15/03/2019
TORONTO and CAMBRIDGE, Mass., March 15, 2019 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting [...]
OncoMed Pharmaceuticals Declares Special Dividend of Contingent Value Rights
15/03/2019
REDWOOD CITY, Calif., March 15, 2019 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (“OncoMed”) (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer [...]
Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
15/03/2019
DUBLIN, Ireland, March 15, 2019 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218 for sleep disorders, today announced its financial results for the fourth quarter and [...]
Oncology Venture receives guarantees and undertakings for a proposed rights issue
15/03/2019
Press release Hoersholm, Denmark, March 15, 2019 – Oncology Venture A/S (Nasdaq First North Stockholm: OV.ST) today announces that its Board of Directors proposes a rights issue of SEK 60-100 million at the coming [...]
Bbs-Bioactive Bone Substitutes Plc: INVITATION TO ANNUAL GENERAL MEETING
15/03/2019
Stock Exchange Release March 15, 2019 at 12:00 am. INVITATION TO THE BBS-BIOACTIVE BONE SUBSTITUTES PLC’S ANNUAL GENERAL MEETING (AGM) The shareholders of BBS-Bioactive Bone Substitutes Plc are invited to the company’s [...]
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
15/03/2019
Company announcement – No. 5 / 2019 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, March 15, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL), a Copenhagen- [...]
Philips showcases integrated portfolio for efficient and effective cardiac care at ACC.19
15/03/2019
March 15, 2019 Amsterdam, the Netherlands and New Orleans, U.S. – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, is highlighting its latest innovations in cardiac care at the ACC.19 68th [...]
Notice to convene Herantis Pharma Plc’s Annual General Meeting of shareholders
15/03/2019
Notice to convene Herantis Pharma Plc’s Annual General Meeting of shareholders Herantis Pharma Plc Company release 15 March 2019 at 9:00 am NOTICE TO CONVENE HERANTIS PHARMA PLC’S ANNUAL GENERAL MEETING OF SHAREHOLDERS [...]
Nicox : signature d'un accord sur ZERVIATE pour la Chine. Paiements d'étape et redevances pouvant atteindre 17 millions d'euros
15/03/2019
Communiqué de presse Nicox : signature d'un accord sur ZERVIATE TM pour la Chine. Paiements d'étape et redevances pouvant atteindre 17 millions d'euros ................................................. 15 mars 2019 - [...]
Nicox signs agreement for ZERVIATE in China for up to €17 million in milestone payments plus royalties
15/03/2019
Press Release Nicox signs agreement for ZERVIATE TM in China for up to €17 million in milestone payments plus royalties ................................................ March 15, 2019- release at 7:30 am CET Sophia [...]
Auris Medical Announces 20-F Filing
15/03/2019
Zug, Switzerland, March 15, 2019 (GLOBE NEWSWIRE) -- March 14, 2019 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in [...]
Syneos Health Schedules Fourth Quarter and Year End 2018 Earnings Call for Monday, March 18, 2019
14/03/2019
MORRISVILLE, N.C., March 14, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization combining a Contract Research Organization (CRO) and Contract [...]

Pages